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Background: Several studies have reported that echolucent carotid lesions, as determined by grayscale median (GSM)
analysis, are associated with increased perioperative embolic complications during carotid artery stenting (CAS). How-
ever, there is limited research of the predictive value of GSM analysis comparing values for primary atherosclerotic lesions
in the carotid artery with those for recurrent lesions after carotid endarterectomy (CEA).
Methods: Retrospective data were collected and analyzed from all patients undergoing CAS from November 2005 to
August 2010. Available preoperative images amenable to GSM analysis were processed in Adobe Photoshop (version
CS4; San Jose, Calif). Statistical analysis included t-test, Fischer exact test, and generation of a receiver operating char-
acteristic curve.
Results:With at least 29 days of follow-up, 212 patients underwent 228 CAS procedures. There were 189 stents placed for
primary lesions (CAS for primary stenosis group) and 39 stents placed for restenosis after CEA (CAS for restenosis
group). GSM analysis was feasible for 47 patients, and the mean GSM was 45.6 (n[ 34; 95% conﬁdence interval, 6 8.3)
for the primary stenosis group and 20.5 (n[ 13; 95% conﬁdence interval, 69.6) for the restenosis group (P < .01). The
mean time from CEA to CAS intervention for the restenosis group was 8.6 years. There was no statistical difference in
procedural individual and combined complications of ipsilateral stroke, 30-day stroke, or 30-day mortality between the
CAS for primary stenosis group and the CAS for restenosis group. In the primary stenosis group, the mean GSM was
lower in those with procedural complications compared with those without complications (15 6 22 vs 49 6 8; P[ .02).
Conclusions: A low GSM value was associated with increased perioperative risk when CAS was performed for native ca-
rotid lesions, but a low GSM value was not associated with higher procedural risk when carotid stenting was performed
for carotid stenosis after CEA (restenosis). GSM analysis for restenosis may be altered by the time interval from CEA to
restenosis. (J Vasc Surg 2014;59:978-82.)Duplex ultrasonography is frequently used to deter-
mine the location and severity of stenotic plaque in the
carotid artery. For more than a decade, there has been
an effort to determine if plaque echogenicity is predictive
of emboli and stroke in the perioperative period. An early
study reported that echolucent plaques were indeed
more likely to cause strokes than echogenic ones, and a
later study found that echolucent plaques were associ-
ated with a higher incidence of recurrent ischemic
events.1,2 Other studies have reported that echolucent
plaques have a higher relative concentration of lipopro-
teins and that they produce more embolic debris than
echogenic lesions as determined by analysis of captured
debris during carotid artery stenting (CAS).3,4 Con-
versely, echogenic plaques tend to be more calciﬁc and
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echodensity seen on B-mode ultrasonography. With use
of Adobe Photoshop (version CS4; San Jose, Calif), ultra-
sound images can be standardized and the GSM value
calculated, categorizing lesions into echolucent plaques
and echogenic plaques. The seminal study of GSM analysis
reported that plaques with a low GSM score correlated
with increased stroke risk during CAS procedures.6 How-
ever, there are few studies that directly compare average
GSM values of primary carotid lesions with those of reste-
notic carotid lesions after carotid endarterectomy (CEA)
and correlate them with procedural outcomes.
METHODS
Comparative analysis of GSM values between patients
who underwent CAS for a primary carotid stenosis (CAS
for primary stenosis group) and patients who underwent
CAS for a carotid restenosis after CEA (CAS for resteno-
sis group) was performed. All patients who underwent
CAS in a single health system from November 2005 to
August 2010 were retrospectively identiﬁed. Demo-
graphics and procedural data were collected and analyzed
for patients. Additional data collected included prior sur-
gical data, atherosclerotic risk factors, procedural data, ul-
trasound images, and long-term outcomes. Patients who
had preoperative images available in the electronic health
record (EHR) and that were amenable to GSM analysis
were identiﬁed as a subset for further investigation.
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deﬁned as those in which the lesion could reasonably be
identiﬁed by B-mode and Doppler data. All ultrasound
images were taken in an Intersocietal Accreditation Com-
mission-certiﬁed laboratory, and all images were validated
by a registered physician in vascular interpretation vascular
surgeon. Image data were attained from multiple EHR
programs.
Ultrasound criteria for the degree of stenosis remained
constant during the 5-year study period. Lesions were clas-
siﬁed into ﬁve grades. Grade I (1%-49% reduction in diam-
eter) was deﬁned as peak internal carotid artery (ICA)
systolic velocity of less than 125 cm/s. Grade II-A (50%-
69% reduction) was deﬁned as peak ICA systolic velocity
of greater than 125 cm/s but less than 325 cm/s with
an ICA/common carotid artery ratio below 4. Grade
II-B (70%-79% reduction) was deﬁned as peak ICA systolic
velocity of greater than 325 cm/s plus ICA/common ca-
rotid artery ratio above 4 with marked spectral broadening.
Grade III (80%-99% reduction) was deﬁned as ICA end-
diastolic velocity of greater than 140 cm/s, and grade
IV (100% occluded) was deﬁned as no Doppler signal in
the ICA.
GSM values were calculated by a single operator with
Adobe Photoshop in the manner previously described in
the literature: preoperative duplex ultrasound images of
the affected artery were collected and each B-mode ultra-
sound image was normalized with use of the scaling
“curves” feature of Adobe Photoshop by setting the me-
dian value of a selected area of adventitia to approximately
185 (of a possible 255; higher values indicate pixels that
have a color closer to white than to black) and an area
of nonaffected lumen to approximately 0 (completely
black). The area of stenosis was then identiﬁed by using
the corresponding Doppler ultrasonography, and the le-
sion’s GSM value was determined from the histogram
feature.7,8
Primary outcomes were any stroke (contralateral or
ipsilateral), death, or procedural complications (composite
stroke and death). Stroke was deﬁned as clinical symptoms
of stroke and its diagnosis in the EHR. Stroke diagnosis in
patients in the GSM subset was conﬁrmed by magnetic
resonance imaging. The individual categories of stroke
and death were recorded by the occurrence of the speciﬁed
event. In contrast, procedural complications were recorded
on a per-patient basis, documenting an incident of proce-
dural complication if either stroke or death occurred. All
outcomes were divided into categories of less than 30
days (procedural) or 30 days or more. Death data were
initially collected from the EHR as available. For patients
with ultrasound images available for subset analysis, the So-
cial Security Death Index was searched to rule out the pos-
sibility that a procedural death was missed because of lack
of documentation in the EHR. Finally, we also report in-
stent restenosis using peak systolic velocities associated
with stenosis greater than 50% as reported in the litera-
ture.9 The value of 50% was chosen to balance sensitivity
and speciﬁcity.Statistics were calculated by Microsoft Excel 2010 and
GraphPad InStat Software. For comparisons between two
group means, a two-tailed Student t-test was used. For
comparisons between discrete outcomes, the Fischer exact
test was employed.
The Eastern Virginia Medical School Institutional Re-
view Board approved the study method and design.
RESULTS
During the 5-year study period, 280 patients under-
went 300 CAS procedures as identiﬁed by Current Proce-
dural Terminology billing code. Excluding those without
data in the EMR software used during the study period
and those without 30-day follow-up data, 212 patients un-
derwent 228 CAS procedures (13 patients had bilateral
CAS procedures, 1 patient was restented once, and 1 pa-
tient was restented twice). The 30-day follow-up data
were not available for 68 patients because of general loss
to follow-up, loss of data during two EHR upgrades during
the study period, and migration of patients from the
procedure-site hospital system to a separate hospital system
for follow-up.
Of the 228 procedures, 111 were performed on a left-
sided carotid lesion and 117 on a right-sided lesion. All
procedures were performed by board-certiﬁed vascular sur-
geons with the exception of one procedure performed by a
neurologic interventional radiologist. The decision to
perform CAS and the speciﬁcs of the technique were
generally left to the surgeon’s discretion, although many
patients included in our study were randomized to CAS
by their inclusion in the Stenting and Angioplasty with Pro-
tection in Patients at High Risk for Endarterectomy (SAP-
PHIRE) trial (n ¼ 105) and the Carotid Stenting vs
Surgery of Severe Carotid Artery Disease and Stroke Pre-
vention in Asymptomatic Patients (ACT 1) trial (n ¼ 9).
All procedures ended in technical success, as deﬁned by
deployment of a carotid stent; 224 procedures had docu-
mented use of an embolic protection device, and 4 proce-
dures had inadequate documentation to determine its use.
Embolic protection devices included Angioguard (Cordis,
Bridgewater, NJ), Vascular Emboshield NAV6 (Abbott,
Chicago, Ill), and Vascular RX Accunet (Abbott). There
were 11 end point complications, including 7 strokes and
4 deaths encountered in 9 procedures.
Ultrasound imagery was available for 54 patients, and
GSM analysis was feasible for 47. Our GSM analysis of
the entire 228 procedures was limited by the lack of digital
availability of preoperative ultrasound images and the qual-
ity of the digital images that were available. Ultrasound im-
ages amenable to GSM analysis were deﬁned as those in
which the lesion could reasonably be identiﬁed by gray-
scale and Doppler data. Demographics, risk factors, and
procedural complications were compared between all pro-
cedures recorded during the trial period (n ¼ 228) and
the procedures analyzed in this GSM subset (n ¼ 47).
There was no difference in age, gender, risk factors, or pro-
cedural complication rate, although coronary artery disease
rate trended higher in the larger population (Table I). Of
Table II. Demographics and risk factors of patients with
GSM analysis (n ¼ 47)
Characteristics
Primary
(n ¼ 34)
Restenosis
(n ¼ 13) P
Mean age, years 71.1 (s ¼ 9.2) 69.3 (s ¼ 8.7) .54
Male 19 (56%) 7 (54%) .80
Hypertensive 30 (88%) 9 (69%) .19
Coronary artery disease 13 (38%) 3 (23%) .49
Prior cerebrovascular
accident
10 (29%) 2 (15%) .46
Octogenarian 8 (24%) 2 (15%) .70
Symptomatic stenosis 13 (38%) 6 (46%) .61
GSM, Grayscale median.
Table III. Primary outcomes for CAS patients with
GSM analysis (n ¼ 47)
Comparison
Primary
(n ¼ 34)
Restenosis
(n ¼ 13) P
Mean GSM, No. (95% CI) 45.6 (68.3) 20.5 (69.6) <.01
<30-day stroke 1 (3%) 0 (0%) 1.0
<30-day mortality 2 (6%) 0 (0%) 1.0
Combined perioperative
stroke and death
3 (9%) 0 (0%) .55
Mean follow-up, months 11 14 .42
Restenosis 4 (12%) 0 (0%) .56
$30-day ipsilateral stroke 3 (9%) 0 (0%) .55
CAS, Carotid artery stenting; CI, conﬁdence interval; GSM, grayscale
median.
Table I. Demographics, risk factors, and procedural
complications: groups comparison
Characteristics
All procedures
(n ¼ 228)
GSM subgroup
(n ¼ 47) P
Mean age, years 71.4 (s ¼ 10.4) 70.6 (s ¼ 9.1) .6
Male 130 (57%) 26 (55%) .9
Hypertensive 202 (89%) 40 (85%) .5
Coronary artery disease 128 (56%) 19 (40%) .06
Prior cerebrovascular
accident
55 (24%) 14 (30%) .5
Octogenarian 57 (25%) 10 (21%) .7
Symptomatic 81a (36%) 19 (40%) .6
Procedural stroke or
death
9 (4%) 3 (6%) .4
GSM, Grayscale median.
aOf 228 procedures, 16 did not have data on symptomatic vs asymptomatic.
Table IV. Intrarestenosis group variation
Comparison
<2 years
from CEA
(n ¼ 2)
$2 years
from CEA
(n ¼ 11) P
GSM, No. (95% CI) 34 (54 to 122.9) 18 (6.9 to 29.1) .22
P vs entire primary
stenosis group
.56 <.01
CEA, Carotid endarterectomy; CI, conﬁdence interval; GSM, grayscale
median.
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categorized into the primary stenosis group and 13 into
the restenosis group. The mean time from CEA to CAS
intervention for the restenosis group was 8.6 years (range,
0.5 to 15 years). The mean age of the primary stenosis
group was 71 years, whereas the mean age of the restenosis
group was 69 years (P ¼ .5). There was no statistical differ-
ence in rates of hypertension, coronary artery disease, or
prior stroke between the two subgroups (Table II).
The most remarkable difference was seen in the GSM
score between the primary and restenosis groups. The
mean GSM value was 46 (95% conﬁdence interval, 6
8.3) for the primary stenosis group and 20 (95% conﬁdence
interval, 6 9.6) for the restenosis group (P < .01). There
was no statistical difference in the procedural complication
rate between these two smaller GSM subgroups or in the
rates of restenosis (deﬁned as lesions with a peak systolic ve-
locity of greater than 224 cm/s) or rates of late stroke in
the follow-up period (Table III). Likewise, there was no
difference in the procedural complication rate when all pro-
cedures were separated into primary (n ¼ 189) and reste-
nosis (n ¼ 39) groups (8 vs 1; P ¼ 1).
To help explain the difference in mean GSM values
between the primary stenosis and restenosis groups,
mean GSM value for the restenosis group was modeledas a function of time from the date of endarterectomy
to the subsequent CAS procedure. The mean GSM value
was 34 for the restenotic lesions that underwent CAS 2
years or less from their original CEA procedures and 18
for the lesions that underwent CAS more than 2 years
from their CEA procedure as seen in Table IV (P ¼
.22). There was no difference in mean GSM value be-
tween the primary group and restenosis limited to lesions
recurring within 2 years (46 vs 34; P ¼ .5), and there was
a signiﬁcant difference in mean GSM value between the
primary group and restenosis occurring after 2 years (46
vs 18; P < .01). Fig 1 shows the mean GSM value for
every 2-year interval from the date of CEA to CAS inter-
vention. There was no statistical difference in mean GSM
value between any of the 2-year intervals, although the
mean GSM value of lesions recurring in less than 2 years
came close to being statistically higher than the
mean GSM value of lesions recurring within 6 to 8 years
(P ¼ .06).
The mean lesion GSM value of primary stenosis with
perioperative complications was lower than that of those
patients in the same group without perioperative complica-
tions (15 6 22 vs 49 6 8; P ¼ .02). Fig 2 shows the
receiver operating characteristic curve generated to deter-
mine the GSM cutoff of 30 between low GSM and high
GSM scores as a function of perioperative complications.
The rate of combined perioperative complications was
30% in patients who had lesions in the low GSM
(GSM < 30) category and 0% in the patients in the high
GSM (GSM $ 30) category (P < .5).
Fig 1. Mean grayscale median (GSM) plotted against time from
carotid endarterectomy (CEA) procedure to carotid artery stenting
(CAS) reintervention. Error bars represent standard error.
Fig 2. Receiver operating characteristic (ROC) curve generated to
determine appropriate grayscale median (GSM) value cutoff. GSM
value of 30 had 100% sensitivity and 80% speciﬁcity.
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Our study found that the mean GSM score was lower
in patients with restenosis than in patients with primary ste-
nosis, but this did not correlate with an increased risk of
complications. We found that low GSM score was associ-
ated with increased perioperative complication rates only
in patients with a primary stenosis. Last, we found that
length of time from CEA to CAS intervention inﬂuenced
the mean GSM value of the lesion at the time of CAS,
although lack of data and access to B-mode images limit
the strength of our conclusions.
One of the ﬁrst large studies concerning GSM analysis
was the Imaging in Carotid Angioplasty and Risk of Stroke
(ICAROS) study, which found that lesions with a GSM
value of less than 25 were associated with more complica-
tions during CAS.6 Other studies have used cutoffs as
high as 50 for low GSM values while still reporting statisti-
cal differences in perioperative complication rates.8 Our
study found an association with perioperative complica-
tions in lesions with a GSM value of less than 30 for
primary carotid lesions. Despite some variability in cut-
off values, reports have consistently described increasedperioperative complication rates in primary lesions with
low GSM values. This suggests that preoperative CAS pa-
tients could undergo ultrasound GSM analysis to stratify
patients into low- and high-risk complication groups.
Those patients stratiﬁed into the high-risk complication
group may beneﬁt from more rigorous embolic protection
during CAS, such as ﬂow reversal used in the Prevention of
Cerebral Embolization by Proximal Balloon Occlusion
Compared to Filter Protection During Carotid Artery
Stenting (PROFI) study, or delay of surgery until the pla-
que has been stabilized by lipid-lowering therapy, which
has been found to increase plaque GSM value when circu-
lating low-density lipoprotein concentration is reduced to
below 100.10,11
Our ﬁnding that mean GSM value is lower in post-
CEA restenosis differs from the ICAROS report that reste-
nosis tended to be associated with a higher GSM value.
This result may be explained in part by the fact that the
average interval time it took for our restenosis group to un-
dergo CAS after CEA was 8.6 years, a length of time that
may be associated with a lower GSM value than restenosis
occurring within 2 years. We also found no difference in
perioperative complication rate between the primary steno-
sis group and the restenosis group. If the mean GSM value
of restenosis is truly higher as suggested by ICAROSdand
if a higher GSM value implies a lower embolic potentialdit
would be expected that the complication rate would be
lower in the restenosis group than in the primary stenosis
group. However, neither ICAROS nor our study reports
a statistical difference in the complication rate between
these two groups. Conversely, if the mean GSM value of
restenosis is lower than that of a primary stenosis (such as
found in our small study population), a higher complica-
tion rate would be expected to be found. As noted before,
it was not.
There are several possible explanations for the discrep-
ancy of the ﬁnding that restenosis and primary stenosis
have similar perioperative complication rates despite having
statistically different mean GSM values. First, our study
population was small and the restenosis group had no com-
plications. Second, it is possible that mean GSM value may
have limited predictive value in the setting of restenosis,
especially when the deﬁnition of restenosis is not limited
to less than 2 years from original intervention.
Related to this, a third possible explanation for the
discrepancy is that restenosis is heterogeneous and the
morphology depends on the time it takes for restenosis
to occur. Fig 1 suggests that GSM values of early restenotic
lesions (<2 years) may be higher than the later ones.
Intimal hyperplasia would be associated with a higher
mean GSM value, whereas recurrent atherosclerotic disease
would be associated with a “normal” or lower mean GSM
value. One study of coronary bare metal stents found that
early in-stent restenosis was homogeneous and less like
atherosclerotic disease than was very late in-stent resteno-
sis, deﬁned as more than 5 years from stent placement.12
If it was determined that early restenosis did indeed have
a higher mean GSM value than later restenosis, it would
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complication rates similar to those of the primary stenosis
group: the early, more stable restenosis is balanced by the
later, less stable restenosis.
One study did limit its deﬁnition of restenosis to
include lesions that developed within 2 years of CEA; it re-
ported that this type of restenosis produced less embolic
debris than primary stenosis lesions and suggested there-
fore that restenosis may not require distal protection.4
This study supports our third hypothesis, but as both
studies found no difference in perioperative complication
rate, we would not recommend foregoing embolic protec-
tion for restenosis, even if it occurred within 2 years of orig-
inal intervention, until our third hypothesis is borne out by
larger studies.CONCLUSIONS
This study conﬁrms that a low GSM value is associated
with increased perioperative risk for patients undergoing
CAS for primary carotid stenosis, but a low GSM value
did not have an impact on perioperative risk for patients
undergoing CAS for restenosis after CEA. Time from
CEA to CAS may also be an important consideration in
evaluating the utility of GSM for predicting perioperative
risk in these restenosis patients, as the GSM value may be
affected by the nature of the restenosis (ie, intimal hyper-
plasia versus recurrent atherosclerosis). Because of this
ﬁnding, we suggest that the time course of restenosis after
CEA and its relation to GSM value should be studied
further with larger numbers of patients.AUTHOR CONTRIBUTIONS
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